MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Association between sleep apnea and prognosis in patients with multiple system atrophy

    S. Jo, S. Lee, J. Lee, SA. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the relationship between sleep apnea and survival or early frequent falls in patients with multiple system atrophy (MSA). Background: Sleep-disordered…
  • 2022 International Congress

    Painful arm spasms after remote electrical injury: focal epilepsy begets causalgia-dystonia?

    J. Cohen, J. Wilkinson (Philadelphia, USA)

    Objective: We describe a case of episodic, painful arm spasms with involuntary tremulous movements, after remote electrocution injury. Background: A variety of movement disorders have…
  • 2022 International Congress

    Availability and accessibility of medicines for patients with Parkinson’s disease in Kyrgyzstan

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the study was to assess the availability and accessibility of medicines for patients with Parkinson’s disease (PD) in Kyrgyzstan. Background: After…
  • 2022 International Congress

    Whole-brain metabolic pattern analysis of faciobrachial dystonic seizures (FBDS)

    J. Mo, K. Zhang, X. Shao (Beijing, China)

    Objective: Whole-brain metabolic network analysis was performed to 1) identify the symptomatic network of faciobrachial dystonic seizures (FBDS); 2) to explore independent neuroimaging predictors; and…
  • 2022 International Congress

    PD-MCI is frequent in candidates to subthalamic deep brain stimulation and is associated with structural brain alterations

    K. Dujardin, Q. Devignes, S. Daoudi, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, AS. Rolland, JC. Corvol, D. Devos (Lille, France)

    Objective: To determine the prevalence of mild cognitive impairment (PD-MCI) in Parkinson's disease (PD) patients, candidates to subthalamic deep brain stimulation (STN-DBS) as well as the frequency…
  • 2022 International Congress

    Evaluation of the effect of adding a mGlu2/3 orthosteric antagonist to a highly selective 5-HT2A antagonist on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

    S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To determine whether the therapeutic effect of serotonin 2A (5-HT2A) receptor antagonism on dyskinesia and psychosis may be reversed by orthosteric antagonism of metabotropic…
  • 2022 International Congress

    Double trouble: Association of malignant melanoma with sporadic and genetic forms of Parkinson’s disease and asymptomatic carriers of related genes in the PPMI study.

    C. Koros, AM. Simitsi, A. Bougea, N. Papagiannakis, I. Pachi, A. Prentakis, R. Antonelou, A. Zahou, I. Beratis, E. Efthymiopoulou, E. Stanitsa, C. Chrysovitsanou, E. Angelopoulou, K. Lourentzos, V. Constantinides, M. Bozi, D. Papadimitriou, A. Bonakis, G. Paraskevas, C. Potagas, S. Papageorgiou, X. Trapali, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: The aim of the present study was to assess the prevalence of malignant melanoma (MM) in sporadic and genetic Parkinson’s disease (PD) patients and…
  • 2022 International Congress

    Imaging Tau in Atypical Parkinsonisms: Meta-Analysis of in vivo PET Imaging Findings

    A. Mena, A. Strafella (Toronto, Canada)

    Objective: To determine the most accurate and reliable tau PET tracers for providing differential diagnosis of PSP and CBD from PD. Background: Parkinsonism is classified…
  • 2022 International Congress

    SARS-CoV-2 Infection and Spinocerebellar Ataxia 12: Demographics, Outcomes and Post- COVID Spectrum

    IS. Singh, VS. Swarup, AKS. Srivastava (New Delhi, India)

    Objective: We aimed to assess the symptoms and long-term symptoms in spinocerebellar ataxia 12 (SCA12) COVID-19 patients. Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
  • 2022 International Congress

    Aberrant visual-related networks in familial cortical myoclonic tremor with epilepsy

    H. Wang, B. Wang, Z. Cen, J. Wang, Y. Zang, D. Yang, Y. Ding, S. Wang, S. Wu, W. Luo (Hangzhou, China)

    Objective: To explore the mechanism of prominent visual-related symptoms and photosensitivity, and to investigate alterations of local brain activity and visual-related networks using resting-state functional magnetic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley